Shopping Cart (0)
My Account

Your Shopping Cart
Biofluid Biopsies and Companion Diagnostics 2014

Biofluid Biopsies and Companion Diagnostics 2014



Biofluid Biopsies and Companion Diagnostics 2014 brings together academic researchers, industry researchers, as well as biotechnology and pharmaceutical companies to explore the expanding and evolving field whereby Circulating Biomarkers of various classes are being evaluated for their potential to be developed into diagnostics for cancer as well as other disease classes.

The Biofluid Biopsies Conference Track focuses primarily on blood-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers.  There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field.

Major theme of this conference track is to explore the potential of various circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for Biofluid-based Biopsies and Patient Monitoring.

The Companion Diagnostics Conference Track brings together presenters from around the world to offer a comprehensive picture from research, commercial, and regulatory perspectives as to the deployment of biomarkers for precision medicine, and technical as well as economic and regulatory considerations in the development of companion diagnostics for the different cancer sub-classes as well as other disease areas.


Keynote Speakers

Michael Heller

Michael Heller
Professor, University of California San Diego

Scott Patterson

Scott Patterson
Executive Director, Medical Sciences, Amgen, Inc.

Walter Koch

Walter Koch
VP, Head of Global Research, Roche Molecular Systems

Klaus Pantel

Klaus Pantel
Director, University Medical Center Hamburg Eppendorf

Robert Wassman

Robert Wassman
Chief Medical Officer, Rosetta Genomics

Dave Hoon

Dave Hoon
Director, Molecular Oncology and Chief of Scientific Intelligence, John Wayne Cancer Institute


Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery World U-Networks




There is currently no news for this conference.
    Keep me updated Select Bio Blog Linked in Twitter LabTube.tv SBOnDemand.com MarketReports.com Research-Store.com